Christopher R. Garrett

7.1k citations
50 papers · 5.3k indexed · 2 hit papers · h-index 25
Topics
Colorectal Cancer Treatments and Studies (21 papers)Gastrointestinal Tumor Research and Treatment (10 papers)Gastric Cancer Management and Outcomes (9 papers)

In The Last Decade

Christopher R. Garrett

49 papers receiving 5.1k citations

Hit Papers

Efficacy and safety of sunitinib in patients with advance...20062026201220192006200750010001.5k

Peers

Christopher R. Garrett
Comparison fields: 5 of 104
  • Oncology 2.8k
  • Pulmonary and Respiratory Medicine 2.4k
  • Molecular Biology 1.4k
  • Gastroenterology 1.1k
  • Surgery 953
Replace J. Randolph Hecht with:
J. Randolph Hecht United States
Jonathan Polikoff United States
Min‐Hee Ryu South Korea
Young Suk Park South Korea
Joan Maurel Spain
Maria Di Bartolomeo Italy
Peter C. Enzinger United States
Samuel E. DePrimo United States
Bruno Landi France
J. T. Hartmann Germany
Christopher R. Garrett relative to J. Randolph Hecht United States J. Randolph Hecht's profile →
Citations per field
00.5×1.5×
J. Randolph Hecht · 1×
Citations per year

Countries citing papers authored by Christopher R. Garrett

Since Specialization
Citations

This map shows the geographic impact of Christopher R. Garrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Garrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Garrett more than expected).

Fields of papers citing papers by Christopher R. Garrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Garrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Garrett. The network helps show where Christopher R. Garrett may publish in the future.

Co-authorship network of co-authors of Christopher R. Garrett

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Garrett. A scholar is included among the top collaborators of Christopher R. Garrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Garrett. Christopher R. Garrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 186
3 71
4 93
5
The heterogeneity of KRAS mutations in colorectal cancer and its biomarker implications: an ever-evolving story
2
6 9
7 43
8 14
9 75
10 124
11 272
12 42
13 26
14 67
15 91
16 38
17 16
18 24
19 5
20
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trialbreakdown →
1930

About Christopher R. Garrett

Christopher R. Garrett is a scholar working on Gastroenterology, Oncology and Hepatology, having authored 50 papers that have together received 5.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (21 papers), Gastrointestinal Tumor Research and Treatment (10 papers) and Gastric Cancer Management and Outcomes (9 papers). The work is most often cited by research in Gastroenterology (1.1k citations), Oncology (2.8k citations) and Hepatology (718 citations). Christopher R. Garrett has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Martin E. Blackstein, Manisha H. Shah, Charles M. Baum, Paolo G. Casali, Jaap Verweij, George D. Demetri, Grant A. McArthur, Xin Huang, Ian Judson and Carlo L. Bello. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026